TLR4 and endothelial dysfunction: In line with these observations, in vitro and in vivo experimental studies have shown that PCSK9 overexpression is positively related to an up-regulation of the TLR4 (Toll-like receptor 4)/NF-κB (nuclear factor-kappa B) proinflammatory pathway, thus contributing to vascular inflammation and endothelial dysfunction [15].